This month marks two years since the United Auto Workers’ (UAW) “stand-up strike.” We made history as a union with that fight ...
Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...
Wall Street has always thrived on secrets. But every so often, a breakthrough comes along that threatens to level the playing ...